Fusion Genomics Corp.

$0.00 CAD

Department
National Research Council Canada
Program
CanExport
Recipient country
Canada
Fiscal year
2019-2020
Agreement period
April 25, 2019 – July 31, 2019
Reference
nrc-cnrc:172-2019-2020-Q1-927439

Published purpose

Fusion Genomics plans to introduce its ONETest Pathogenome, which will diagnose all known human pathogens, to the United Kingdom with the objective to close 1-2 pilot projects with KOL hospitals.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions